RE:RE:RE:If Medipharm continues to improve QOQRetail shareholders voting turnout is very low, I'd be surprised to see more than 20% of the issued shares casting proxy..low turnout year after year, no wonder shareholders appear to be an afterthought...over two years of stagnant share price is long enough, it's time for them to show some accountability to shareholders....I voted withhold...the business is going well but not enough is being done for shareholders...information could be disclosed to aid in valuation...Pidduck hasn't given one interview...instead he's been given >30m and counting shares...I wouldn't be at all surprised to see a board supported takeover in the .13-.15c range...WTF is up with the expanded partnership with Avicanna...epidiolex generic Keith is preparing for...hope facility, Brazilian ANVISA product approvals, I understand some things should be on the hush for competitive reasons but some things no...one product has recently been approved in Brazil...what is it and who is the partner....IMO merger or takeover talks are mature and may be hinging on final, official U.S rescheduling.....4 earnings calls one AGM...2023 Y/E was finished by scheduled start time with ZERO warning....WTF happened that day, NO explanation....either complete disgregard, disrespect for shareholders or something significant or unexpected began...we will see......vote....they need a reminder we exist.